Pharmalot By Ed Silverman Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Biotech By Allison DeAngelis Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
Pharmalot By Ed Silverman Greece plans to go to court to seek compensation from Novartis over a bribery scandal
Pharmalot By Ed Silverman Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
In the Lab By Helen Branswell Study suggests risk of sexual transmission of Zika may dissipate quickly
Health By Andrew Joseph Not just Zika: Other mosquito-borne viruses may cause birth defects, study suggests
Health By Helen Branswell Zika-affected babies show severe health, developmental issues two years later
Health By Usha Lee McFarling Deadly West Nile virus cases are spiking in LA. The first line of defense: chickens
In the Lab By Helen Branswell The race for a Zika vaccine slows, a setback for efforts to head off future outbreaks
Pharmalot By Ed Silverman Sanders proposes ‘fair pricing’ requirement for drugs created with taxpayer dollars
Health By Helen Branswell Can Zika infection attack the brains of newborns? Scientists head to field for answers
Health By Helen Branswell ‘Part of the new reality’: Despite confusion, Zika warnings are here to stay
Exclusive By Helen Branswell Feud erupted between CDC, Puerto Rico over reporting of Zika cases, document shows
Pharmalot By Ed Silverman Army rejects request to deny Sanofi an exclusive license for a Zika vaccine
Health By Associated Press Florida tests bacteria-infected mosquitoes to kill off Zika and other viruses
Health By Helen Branswell ‘They’re just hiding’: Experts say Puerto Rico may be underreporting Zika-affected births
First Opinion By Amesh A. Adalja Gaps in care for babies with Zika highlight a deeper problem in medicine